Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

NVCTNVCT
10 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in NUVECTIS PHARMA INC

Bank of New York Mellon Corp holds 36,770 shares of NVCT (NUVECTIS PHARMA INC), worth $676,192 as of 2026-Q2. The position was increased (+21.3% shares). NVCT represents 0.0% of Bank of New York Mellon Corp's portfolio.

Current Value

$676,192

Current Shares

36,770

Total Value Change

+$370,366

Total Shares Change

+17,620

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
36,770
+21.3%
$676,1920.0%$18.39
29
2026-Q1
Decreased
30,315
-4.2%
$234,3320.0%$8.71
0
2025-Q4
Increased
31,635
+12.7%
$238,8470.0%$7.38
18
2025-Q3
Increased
28,071
+3.0%
$168,9840.0%$5.92
16
2025-Q2
New
27,239
-
$203,4730.0%$7.55
35
2024-Q2
Exited
0
-100.0%
$00.0%$6.33
0
2024-Q1
Decreased
17,755
-7.3%
$145,5910.0%$8.20
0
2023-Q4
Unchanged
19,150
0.0%
$159,7120.0%$8.34
0
2023-Q3
Unchanged
19,150
0.0%
$246,8440.0%$12.89
0
2023-Q2
New
19,150
-
$305,8260.0%$16.34
32

Other major holders of NVCT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used